@krispi
Thank you for your excellent post.
I agree with the medical aspects.
I disagree with the 1 in 250 chance valuation calculation. That would be correct if no more expenditure was required to reach drug approval stage. But there's a lot more expenditure required to reach drug approval stage. The market is taking that into account, although maybe inaccurately.
- Forums
- ASX - By Stock
- XanaHES and its implications for Actinogen
@krispiThank you for your excellent post.I agree with the...
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
|
|||||
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $215.9M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 59000 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.5¢ | 250000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 59000 | 0.085 |
3 | 176984 | 0.080 |
5 | 72743 | 0.079 |
2 | 270000 | 0.078 |
2 | 437092 | 0.077 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 250000 | 1 |
0.077 | 45000 | 1 |
0.078 | 60000 | 2 |
0.079 | 60000 | 1 |
0.080 | 45380 | 3 |
Last trade - 09.56am 25/07/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
Day chart unavailable
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online